MK-801
noncompetitive N-methyl-D-aspartate
anticonvulsant effects
rats
seizure models
coadministration
lithium
pilocarpine
administration
high dose
pilocarpine
results
pretreatment
MK-801
effective
dose-dependent
anticonvulsant action
lithium-pilocarpine model
rats
treated
pilocarpine
biochemical
mechanisms
models
anticonvulsant effect
MK-801
lithium-pilocarpine model
periods
seizure
activity
observation
in vivo
in vitro
MK-801
binding
agonist-induced opening
channel sites
NMDA receptor
block seizures
induced
lithium
pilocarpine
administration
anticonvulsants
pilocarpine
status epilepticus
block
lethality
seizures
Administration
MK-801 30
pilocarpine
status epilepticus
reduced
electrical
behavioral seizure
activity
enhanced
survival rate
results
activation
NMDA receptors
status epilepticus
brain damage
lithium-pilocarpine model
results
nonconvulsive
doses
NMDA
pilocarpine
synergistic
status epilepticus
mortality
